Koninklijke Philips (NYSE:PHG) Sets New 52-Week Low - Time to Sell?

Key Points

• Koninklijke Philips shares fell 2.6% to a new 52-week low of $23.85, below both its 50-day and 200-day moving averages.
• Despite beating quarterly EPS and revenue estimates, Philips reported a 3.0% year-over-year revenue decline; analysts expect $1.75 in EPS for the current fiscal year.
• Analyst sentiment remains cautious, with a consensus “Hold” rating from five analysts. Institutional investors own 13.67% of the company, with several firms recently increasing their positions.

Koninklijke Philips N.V. (NYSE:PHG - Get Free Report) hit a new 52-week low during trading on Thursday. The company traded as low as $23.85 and last traded at $23.7820, with a volume of 326091 shares. The stock had previously closed at $24.43.

Wall Street Analysts Forecast Growth

PHG has been the topic of several research analyst reports. UBS Group reaffirmed a "neutral" rating on shares of Koninklijke Philips in a research note on Monday, August 3rd. Zacks Research upgraded shares of Koninklijke Philips from a "strong sell" rating to a "hold" rating in a report on Thursday, August 13th. Finally, Weiss Ratings raised shares of Koninklijke Philips from a "hold (c)" rating to a "hold (c+)" rating in a research report on Tuesday, August 4th. Five equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of "Hold".

Koninklijke Philips Trading Down 2.6%

The company has a 50 day moving average of $26.01 and a 200 day moving average of $26.69. The firm has a market cap of $23.39 billion, a P/E ratio of 17.53, a PEG ratio of 10.28 and a beta of 0.76. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.82 and a current ratio of 1.26.

Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its earnings results on Monday, July 27th. The technology company reported $0.57 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.17. The firm had revenue of $4.98 billion during the quarter, compared to analysts' expectations of $4.91 billion. Koninklijke Philips had a net margin of 6.30% and a return on equity of 14.38%. During the same period in the previous year, the company earned $0.27 earnings per share. The company's revenue was down 3.0% compared to the same quarter last year. Analysts predict that Koninklijke Philips N.V. will post 1.75 EPS for the current fiscal year.

Institutional Investors Weigh In On Koninklijke Philips

A number of large investors have recently bought and sold shares of the business. Whipplewood Advisors LLC raised its holdings in Koninklijke Philips by 923.7% during the first quarter. Whipplewood Advisors LLC now owns 993 shares of the technology company's stock valued at $27,000 after buying an additional 896 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Koninklijke Philips during the 2nd quarter worth about $47,000. Hilton Head Capital Partners LLC bought a new stake in shares of Koninklijke Philips during the 4th quarter worth about $56,000. Bessemer Group Inc. increased its holdings in shares of Koninklijke Philips by 19.8% during the 1st quarter. Bessemer Group Inc. now owns 2,756 shares of the technology company's stock valued at $76,000 after acquiring an additional 456 shares during the last quarter. Finally, Root Financial Partners LLC increased its holdings in shares of Koninklijke Philips by 43.0% during the 4th quarter. Root Financial Partners LLC now owns 4,364 shares of the technology company's stock valued at $118,000 after acquiring an additional 1,313 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. is a Netherlands-based health technology company that develops products, services and software for healthcare providers, health systems and consumers. The company focuses on improving diagnosis, treatment and health management through connected technologies and data-enabled solutions.

Philips' healthcare portfolio includes diagnostic imaging systems such as magnetic resonance imaging, computed tomography and ultrasound equipment; image-guided therapy systems; patient monitoring and clinical informatics technologies; and solutions for sleep and respiratory care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.